Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

BCART

Biocartis Group NV (BCART)

Biocartis Group NV
일자:
정렬 기준:
 검색 관련기사 보기:EU:BCART
일자시간출처헤드라인심볼기업
2024/05/0914:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meetingEU:BCARTBiocartis Group NV
2024/01/1107:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)EU:BCARTBiocartis Group NV
2024/01/1107:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)EU:BCARTBiocartis Group NV
2023/11/2218:00GlobeNewswire Inc.Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansionEU:BCARTBiocartis Group NV
2023/11/1315:00GlobeNewswire Inc.Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual MeetingEU:BCARTBiocartis Group NV
2023/10/3123:55GlobeNewswire Inc.Press release Biocartis Group NV: Announcement regarding Enforcement by Secured CreditorsEU:BCARTBiocartis Group NV
2023/10/2014:00GlobeNewswire Inc.Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)EU:BCARTBiocartis Group NV
2023/10/1614:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer PortfolioEU:BCARTBiocartis Group NV
2023/10/1214:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations KitEU:BCARTBiocartis Group NV
2023/10/0314:00GlobeNewswire Inc.Press Release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
2023/09/2614:00GlobeNewswire Inc.Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding companyEU:BCARTBiocartis Group NV
2023/09/2614:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalizationEU:BCARTBiocartis Group NV
2023/09/2114:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023EU:BCARTBiocartis Group NV
2023/08/2814:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leadersEU:BCARTBiocartis Group NV
2023/08/2414:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023EU:BCARTBiocartis Group NV
2023/08/1014:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ PlatformEU:BCARTBiocartis Group NV
2023/07/1814:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service DeliveryEU:BCARTBiocartis Group NV
2023/06/3014:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of Outstanding Voting SecuritiesEU:BCARTBiocartis Group NV
2023/06/2100:40GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
2023/06/1600:15GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction programEU:BCARTBiocartis Group NV
2023/06/0814:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
2023/06/0600:40GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces resignation CFOEU:BCARTBiocartis Group NV
2023/05/1300:40GlobeNewswire Inc.Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023EU:BCARTBiocartis Group NV
2023/05/0914:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer TestEU:BCARTBiocartis Group NV
2023/04/2900:40GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of Outstanding Voting SecuritiesEU:BCARTBiocartis Group NV
2023/04/2014:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023EU:BCARTBiocartis Group NV
2023/04/1205:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEOEU:BCARTBiocartis Group NV
2023/04/1114:01GlobeNewswire Inc.Press release Biocartis Group NV: Invitation to the Annual Shareholders’ MeetingEU:BCARTBiocartis Group NV
2023/04/1114:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual ReportEU:BCARTBiocartis Group NV
2023/04/0414:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platformEU:BCARTBiocartis Group NV
 검색 관련기사 보기:EU:BCART